MED 8710 Core Experiences
Pediatrics Core Rotation
Phase 4, Class of 2023
Academic Year 2021-2022

Assessment Plan 
All aspects of this assessment plan to be completed at a satisfactory level as determined by the discipline.
 
EPAs that can be assessed in this rotation:
EPA 1: Obtain a history and perform a physical examination adapted to the patient’s clinical situation.
EPA 2: Formulate and justify a prioritized differential diagnosis.
EPA 3: Formulate an initial plan of investigation based on the diagnostic hypotheses.
EPA 4: Interpret and communicate results of common diagnostic and screening tests.
EPA 5: Formulate, communicate and implement management plans.
EPA 6: Present oral and written reports that document a clinical encounter.
EPA 7: Provide and receive the handover in transitions of care.
EPA 8: Recognize a patient requiring urgent or emergent care, provide initial management and seek help.
EPA 10: Participate in health quality improvement initiatives.
EPA 13: Collaborate as a member of an interprofessional team.
EPA 14: Incorporate the relevant social determinants of health (SDoH) and cultural safety in relation to patient’s illness and management planning.
 
Any of EPAs 1-13 can be assessed if requested by the learner or preceptor, or assigned in the learning plan. EPA 14 is included as a pilot and can be assessed as deemed appropriate by the learner or preceptor. Inclusion of EPA 14 in any assessments is strongly encouraged but not required.
 
Formative
Mini-CEX in first part of rotation
Clinic cards (T-Res): 1 card per shift for ER; 1 card per clinic; 2 cards per week for wards (1 staff, 1 resident)
Prescribed Clinical Experiences (T-Res)
Mid-Term Assignment
Completion of CLiPP cases
Health Advocate Essay
 
Summative
In-Training Assessment Reports (ITARs)
Mini-CEX
 
Clinic card requirements by rotation:
Please note that these are the minimum required and it benefits the learner to request/record feedback at multiple opportunities to best reflect their performance.
 
All aspects of this assessment plan will be collated and presented at the Phase 4 Comprehensive Reviews at 6, 9, and 12 months.


Version date: April 21, 2021
Approved by SAS: April 28, 2021
Approved by UGMS: May 19, 2021